Christopher Klein

Insider Reports History

Location
Bridgewater, NJ
Signature
/s/ Christopher Klein
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Christopher Klein:

Company Role Class Num Shares Value Price $ Report Date Ownership
RVL Pharmaceuticals plc General Counsel & Secretary Ordinary Shares 180,573 $5,634 $0.0312 18 May 2023 Direct

Insider Reports Filed by Christopher Klein

Symbol Company Period Transactions Value $ Form Type Role Filing Time
/report/000110465923063321-klein-christopher-2023-05-18 RVL Pharmaceuticals plc 18 May 2023 1 -$4,739 4 General Counsel & Secretary 22 May 2023, 21:18
/report/000110465923007069-klein-christopher-2023-01-24 RVL Pharmaceuticals plc 24 Jan 2023 1 -$12,106 4 General Counsel & Secretary 26 Jan 2023, 16:16
/report/000110465922063392-klein-christopher-2022-05-18 RVL Pharmaceuticals plc 18 May 2022 1 -$8,578 4 General Counsel & Secretary 20 May 2022, 16:27
/report/000110465922007843-klein-christopher-2022-01-24 RVL Pharmaceuticals plc 24 Jan 2022 1 -$10,856 4 General Counsel & Secretary 26 Jan 2022, 15:31
/report/000110465921135639-klein-christopher-2021-11-04 Osmotica Pharmaceuticals plc 04 Nov 2021 1 $0 4 General Counsel & Secretary 08 Nov 2021, 15:06
/report/000110465921069881-klein-christopher-2021-05-18 Osmotica Pharmaceuticals plc 18 May 2021 1 -$20,177 4 General Counsel & Secretary 20 May 2021, 16:06